prodchem
Aug 20, 2026
The rapid growth in demand for metabolic drugs, particularly medicines used for diabetes and weight management, has created new opportunities for counterfeit and falsified products to enter informal and online markets. Regulators and health organizations have increasingly warned about products that misrepresent their identity, composition, or source.
This development offers a useful parallel for the agrochemical industry, where counterfeit and illegally marketed pesticides can similarly bypass regulatory controls and enter agricultural supply chains.
Although medicines and pesticides are fundamentally different product categories, the underlying enforcement challenge is similar: high demand, price differences, informal distribution channels, and complex supply chains can create opportunities for counterfeit products.
The rapid increase in demand for metabolic medicines has contributed to greater pressure on legitimate supply chains. The World Health Organization (WHO) has reported increased falsification of semaglutide products across multiple regions, with shortages and unmet demand creating conditions in which unauthorized sellers can gain access to consumers.
In 2024, WHO issued an alert concerning falsified Ozempic products detected in Brazil, the United Kingdom, and the United States. Some of the falsified products had even entered regulated supply chains, demonstrating how counterfeit products can move beyond informal markets and penetrate legitimate distribution networks.
A similar dynamic can occur in agricultural chemicals when farmers face high prices, limited availability, or difficulty accessing specific crop protection products.
Counterfeit products are not simply a problem of unauthorized sellers. They can expose weaknesses across the entire supply chain.
In the pharmaceutical sector, regulators have identified counterfeit products carrying authentic-looking packaging, lot numbers, and manufacturer information. In one 2025 case, the U.S. Food and Drug Administration (FDA) reported counterfeit Ozempic carrying a lot number that was also associated with an authentic product.
This illustrates an important lesson for agrochemical manufacturers: packaging and labeling alone may not always be sufficient to establish authenticity.
Counterfeit pesticides can also be smuggled, falsely labeled, unregistered, or manufactured outside approved systems. FAO reported in 2026 that illegal and counterfeit pesticides pose risks to human health, the environment, crops, and fair trade because they can bypass safety checks and quality controls.
Counterfeit and illegal pesticides can create significant problems for agricultural supply chains.
Farmers purchasing counterfeit products may receive formulations with incorrect concentrations, undeclared ingredients, or no effective active ingredient. This can lead to poor pest control, crop damage, unnecessary repeat applications, and potential environmental contamination.
For manufacturers, counterfeit products can also damage brand reputation and create uncertainty around product performance.
The challenge becomes more complicated when unauthorized products move through multiple intermediaries before reaching the end user.
The growth of digital commerce has made it easier for unauthorized sellers to reach customers directly.
WHO has specifically identified online and informal markets as important channels for falsified medical products.
The same structural issue is relevant to agrochemicals. Digital marketplaces, social media, messaging platforms, and informal distributor networks can make it more difficult for regulators and manufacturers to determine where products originated and whether sellers are authorized.
This means counterfeit enforcement increasingly requires digital monitoring alongside traditional physical inspections.
The pharmaceutical sector provides several useful lessons for agrochemical manufacturers.
Manufacturers need visibility across the distribution chain rather than focusing only on production quality.
Tracking products through authorized distributors, wholesalers, retailers, and other intermediaries can make it easier to identify unusual movements or unauthorized sales.
Serialization, QR codes, tamper-evident packaging, batch verification, and digital authentication systems can make counterfeit products more difficult to introduce into legitimate channels.
However, authentication systems are most effective when they are connected to reliable databases and actively monitored.
Counterfeit enforcement should increasingly include digital channels.
Manufacturers can monitor online listings for unusual pricing, unauthorized sellers, suspicious product descriptions, incorrect packaging, or products being offered in markets where they are not registered.
Counterfeit enforcement requires coordination between manufacturers, distributors, regulators, customs authorities, marketplaces, and law-enforcement agencies.
The WHO's approach to falsified medical products demonstrates the importance of information sharing between regulatory authorities and supply-chain stakeholders.
A comparable information-sharing framework could strengthen the detection of counterfeit pesticides.
One of the most important lessons from counterfeit medicine enforcement is the value of end-to-end traceability.
A product should ideally be traceable from manufacturing through distribution and ultimately to the customer. If a suspicious product is discovered, companies should be able to determine its batch, manufacturing location, distributor, and movement through the supply chain.
For agrochemical manufacturers, this can help distinguish genuine products from unauthorized or counterfeit material and accelerate investigations when suspicious products appear in the market.
Counterfeit markets generally develop where there is an economic incentive to imitate legitimate products.
High-value products, strong consumer demand, supply shortages, and price differences can increase the attractiveness of unauthorized production and distribution.
This is evident in the metabolic drug market, where WHO has linked increased demand and limited access with greater risks of falsified products.
Agrochemical companies face similar pressures when popular crop protection products experience supply constraints or significant price differences between markets.
Traditional enforcement methods such as factory inspections, border controls, and physical product testing remain important. However, modern counterfeit markets require a broader approach.
Regulators and manufacturers increasingly need to combine:
Supply-chain traceability.
Product authentication.
Online marketplace monitoring.
Laboratory testing.
Customs and border enforcement.
Distributor verification.
Data sharing between stakeholders.
Rapid reporting and product recalls.
FAO's recent work on illegal and counterfeit pesticides emphasizes the importance of coordinated policy, enforcement, and sustainable agrochemical management.
Counterfeit risks also have implications for procurement teams.
Buyers should evaluate not only price and availability but also supplier legitimacy, product registration, traceability, documentation, and distribution history.
An unusually low price may be attractive in the short term but can represent a significant operational risk if the material is counterfeit or does not meet required specifications.
For chemical marketplaces and digital procurement platforms, supplier verification and product authentication can therefore become important components of platform security.
The experience of metabolic drugs demonstrates that counterfeit markets can expand quickly when strong demand meets supply constraints and informal distribution channels.
For agrochemical companies, this provides a warning rather than a direct comparison. The products, regulations, and end-use risks differ, but the underlying vulnerabilities of complex supply chains are comparable.
As agricultural procurement becomes increasingly digital, manufacturers and marketplaces may need to invest more heavily in traceability, authentication, supplier verification, and real-time monitoring.
The rise of counterfeit and falsified metabolic drugs provides a valuable cautionary parallel for the agrochemical industry.
Recent pharmaceutical enforcement cases show that counterfeit products can penetrate even legitimate supply chains and may use sophisticated packaging or product information to appear genuine.
For agrochemical manufacturers, the lesson is clear: counterfeit enforcement cannot rely solely on physical inspections or packaging checks. Stronger traceability, digital monitoring, supplier verification, product authentication, and cooperation between industry and regulators will be increasingly important.
As counterfeit markets become more sophisticated, supply-chain visibility itself is becoming an important layer of product protection.
Featured Product
Found this useful?
Continue Reading
C&EN's August 18 Business Watch highlights two defining 2026 industry themes: BASF's historic Ludwigshafen workforce contraction and Khartis Therapeutics' launch, offering a snapshot of chemical restructuring and pharmaceutical innovation.
Eli Lilly's retatrutide enforcement campaign highlights why pharmaceutical manufacturers and regulatory agencies increasingly need coordinated strategies to address illicit compound markets. Faster market development is creating new challenges around monitoring, traceability and enforcement.
Eli Lilly's 2026 retatrutide crackdown offers a new benchmark for measuring the rapidly expanding illicit weight-loss drug market against prior-year GLP-1 enforcement and seizure data.
